<DOC>
	<DOCNO>NCT01448785</DOCNO>
	<brief_summary>The main objective post-market surveillance study compare subject 's weight loss quality life , device safety performance abiliti System adjustable gastric banding therapy obese morbidly obese subject .</brief_summary>
	<brief_title>Abiliti™ Treatment Obese Subjects</brief_title>
	<detailed_description>This study intend provide additional data regard performance safety abiliti system comparison gastric banding . The composite end-point study design provide direct comparison effectiveness device treatment obesity give consideration safety profile device impact patient quality life .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>Age 18 60 year old time screen BMI 40 55 35 39 obesity relate comorbid condition time screen History obesity ≥5 year The subject routine care investigator another single physician supply medical record least 6 month prior enrollment Women childbearing potential ( i.e. , postmenopausal surgically sterilize ) must agree use adequate birth control methods No significant weight loss ( &lt; 5 % ) within four month prior enrollment document subject 's medical record . Successful psychological evaluation follow institution psychological evaluation protocol bariatric surgery successful historic assessment perform 6 month prior enrollment . Glycosylated Hemoglobin ; HbA1c ≤ 7.0 % Visit 2 historic value perform 3 month prior enrollment . If take antidepressant medication , must stable least six month prior enrollment Willingness refrain use prescription , counter herbal weight loss product duration trial Alert , mentally competent , able understand willing comply requirement clinical trial , personally motivate abide requirement restriction clinical trial Able provide voluntary inform consent Any prior bariatric surgery Other implanted electrical stimulation device ( e.g . pacemaker , defibrillator , neurostimulator ) Diagnosed past current psychiatric condition may impair his/her ability comply study procedure Use antipsychotic medication Diagnosed eat disorder bulimia binge eat Obesity due endocrinopathy ( e.g . Cushing disease ) Insulin therapy GI disease hiatal hernia ( &gt; 5cm ) , gastroparesis , esophageal motility disorder intractable constipation . Cirrhosis , chronic pancreatitis History intestinal obstruction adhesive peritonitis Any history peptic ulcer disease within 5 year prior enrollment Women pregnant , lactate anticipate become pregnant within 24 month Arthritis pathology limit physical activity physician feel exclude patient study . Chronic use aspirin and/or non steroidal antiinflammatory medication unwillingness discontinue use Cardiac history physician feel exclude patient study . Concurrent use weight loss medication . Use another investigational device agent 30 day prior enrollment A history lifethreatening disease within 5 year prior enrollment Any condition , opinion investigator , would make subject unsuitable study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>obesity</keyword>
	<keyword>gastric stimulation</keyword>
	<keyword>morbid obesity</keyword>
</DOC>